Rev Esp Quimioter 2022; 35(6):589-591

Nirmatrelvir/ritonavir as a potential treatment for prolonged SARS-CoV-2 infection in immunocompromised patients

IGNACIO PÉREZ CATALÁN, SERGIO GARCÍA MUÑOZ, CELIA ROIG MARTÍ, IRIS GÓMEZ ALFARO, LUIS SERRANO PICAZO, MIGUEL TORRES GARCÍA, ROBERTO REIG VALERO, RAÚL FERRANDO PIQUERES, LIDÓN MATEU CAMPOS, JOSÉ MANUEL RAMOS RINCÓN, JORGE USÓ BLASCO

Published: 18 October 2022

LETTER TO THE EDITOR

http://www.doi.org/10.37201/req/078.2022

Rev Esp Quimioter 2022; 35(6):589-591  [Texto completo PDF] [Full-text PDF]